Based on Oxford and Sao Paulo State University research, Osler Diagnostics is reportedly set to secure $38m to add to the $2.6m it raised in 2016.

Osler Diagnostics, a UK-based handheld diagnostic device developer based on University of Oxford and Sao Paulo State University in Brazil research, is raising £30m ($38m) in funding, Sky News has reported.
The round is reportedly being led by an unspecified venturing vehicle owned by Michael Spencer, founder of electronic markets business Nex Group, and no other investors were mentioned in the report.
Founded in 2016 as Oxford Impedance Diagnostics, Osler Diagnostics is working on a handheld diagnostic device that tests patients for cancers as well as cardiovascular and neurological diseases, by scanning for biomarkers from a drop of blood.
Osler’s test works by quantifying the specific antibodies, proteins and other biomarkers present within a given blood sample, by identifying the sample’s associated impedance and capacitance signals.
The device would function without external laboratory testing and is designed to be highly accessible to suit applications in the…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?